Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

Former Palantir Technologies Inc. adviser Jacob Helberg plans to retain investments in dozens of artificial intelligence, ...

At just 21 years old, Ethan Thornton is rewriting the rules of modern warfare. He's the founder and CEO of Mach Industries, a ...

Investors have reaped billions of dollars in gains from backing database software firms Snowflake and Databricks. Now venture ...

The numbers for the most-active startup investors in the U.S. certainly bear that out, as Andreessen Horowitz and Khosla ...

Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, closed its Series A funding round, raising more than $47 million. The round ...

Tech titans and DC policymakers sound the alarm on China's AI and defense tech surge at the high-powered Hill and Valley ...

NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has ...

Tech giants like to boast about trillion-parameter AI models that require massive and expensive GPU clusters. But Fastino is taking a different approach. The Palo Alto-based startup says it’s invented ...